LUCID CAPITAL MARKETS Initiates Coverage On LENSAR with Buy Rating, Announces Price Target of $11

9/28/2026
Impact: 75
Healthcare

LUCID CAPITAL MARKETS has initiated coverage on LENSAR (NASDAQ: LNSR) with a Buy rating. The firm has set a price target of $11 for the stock.

AI summary, not financial advice

Share: